Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
Randomized, open-label, parallel-group phase III trial to prove an additional benefit of the
full-spectrum cannabis extract VER-01 over opioids in patients with chronic non-specific low
back pain for whom drug treatment is indicated and previous optimized treatments with
non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to
contraindications or intolerance.